MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202417097461 A) filed by Nucana Plc, Edinburgh, U.K., on Dec. 10, 2024, for 'cancer treatment with nuc-7738.'
Inventor(s) include Harrison, David James; and Elshani, Mustafa.
The application for the patent was published on March 14, under issue no. 11/2025.
According to the abstract released by the Intellectual Property India: "The invention provides NUC-7738 (3'-deoxyadenosine-5'-O-[phenyl(benzyloxy-L-alaninyl)] phosphate), a phosphoramidate derivative of 3'-deoxyadenosine, for use in the treatment of a proliferative disease, such as cancer, by reducing the amount of extra-cellular PD-L1 protein (e.g. soluble PD-L1 or exosomal PD L1) and/or increa...